Novel function of PiT1/SLC20A1 in LPS-related inflammation and wound healing.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
12 02 2019
Historique:
received: 02 05 2018
accepted: 27 11 2018
entrez: 14 2 2019
pubmed: 14 2 2019
medline: 1 9 2020
Statut: epublish

Résumé

PiT1/SLC20A1 is an inorganic phosphate transporter with additional functions including the regulation of TNFα-induced apoptosis, erythropoiesis, cell proliferation and insulin signaling. Recent data suggest a relationship between PiT1 and NF-κB-dependent inflammation: (i) Pit1 mRNA is up-regulated in the context of NF-κB pathway activation; (ii) NF-κB target gene transcription is decreased in PiT1-deficient conditions. This led us to investigate the role of PiT1 in lipopolysaccharide (LPS)-induced inflammation. MCP-1 and IL-6 concentrations were impaired in PiT1-deficient bone marrow derived macrophages (BMDMs) upon LPS stimulation. Lower MCP-1 and IL-6 serum levels were observed in Mx1-Cre; Pit1

Identifiants

pubmed: 30755642
doi: 10.1038/s41598-018-37551-1
pii: 10.1038/s41598-018-37551-1
pmc: PMC6372663
doi:

Substances chimiques

Lipopolysaccharides 0
NF-kappa B 0
Pit1 protein, mouse 0
Reactive Oxygen Species 0
Slc20a1 protein, mouse 0
Sodium-Phosphate Cotransporter Proteins, Type III 0
Thioglycolates 0
Transcription Factor Pit-1 0
Tumor Necrosis Factor-alpha 0
NADPH Oxidase 2 EC 1.6.3.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1808

Références

Immunity. 1999 Apr;10(4):421-9
pubmed: 10229185
Immunity. 1999 Jul;11(1):115-22
pubmed: 10435584
Oncogene. 1999 Nov 22;18(49):6853-66
pubmed: 10602461
Genes Dev. 2000 Apr 1;14(7):854-62
pubmed: 10766741
Endocrinology. 2000 Jun;141(6):2236-43
pubmed: 10830313
Arthritis Res. 2001;3(2):118-26
pubmed: 11178119
Am J Pathol. 2001 Aug;159(2):387-97
pubmed: 11485895
Endocrinology. 2001 Nov;142(11):4969-75
pubmed: 11606465
Physiol Rev. 2002 Jan;82(1):47-95
pubmed: 11773609
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Nature. 2002 Apr 11;416(6881):648-53
pubmed: 11923872
Diabetes. 2002 May;51(5):1319-36
pubmed: 11978627
Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11181-6
pubmed: 12177410
J Endotoxin Res. 2003;9(1):55-9
pubmed: 12691620
Oncogene. 2003 May 22;22(21):3307-18
pubmed: 12761501
In Silico Biol. 2003;3(1-2):71-9
pubmed: 12762847
Nature. 2004 Apr 1;428(6982):1 p following 486
pubmed: 15058298
J Exp Med. 2004 Jul 5;200(1):107-13
pubmed: 15226358
J Virol. 1992 Mar;66(3):1635-40
pubmed: 1531369
J Endotoxin Res. 2004;10(6):419-24
pubmed: 15588425
J Biol Chem. 2006 Mar 3;281(9):5657-67
pubmed: 16407283
EMBO J. 2006 Feb 22;25(4):798-810
pubmed: 16467852
Ann Rheum Dis. 2007 Jan;66(1):121-3
pubmed: 16740681
Annu Rev Cell Dev Biol. 2006;22:409-37
pubmed: 16822173
Cell Mol Immunol. 2007 Feb;4(1):31-41
pubmed: 17349209
Endocr Rev. 2007 Jun;28(4):365-86
pubmed: 17431229
Science. 2007 Aug 3;317(5838):675-8
pubmed: 17673665
Mol Cell. 2007 Oct 12;28(1):15-27
pubmed: 17936701
Cell Microbiol. 2008 Mar;10(3):741-54
pubmed: 18028450
Am J Pathol. 2007 Dec;171(6):1789-99
pubmed: 18055544
Cell. 2008 Feb 8;132(3):344-62
pubmed: 18267068
Nature. 2008 Oct 9;455(7214):813-7
pubmed: 18716620
J Interferon Cytokine Res. 2009 Jun;29(6):313-26
pubmed: 19441883
Nat Rev Mol Cell Biol. 2009 Aug;10(8):550-63
pubmed: 19626045
J Immunol. 2009 Sep 1;183(5):3463-71
pubmed: 19641140
J Biol Chem. 2009 Nov 6;284(45):31363-74
pubmed: 19726692
Genesis. 2009 Dec;47(12):858-63
pubmed: 19882669
PLoS One. 2010 Feb 10;5(2):e9148
pubmed: 20161774
Thromb Haemost. 2010 Sep;104(3):464-70
pubmed: 20664908
Bone. 2010 Nov;47(5):938-47
pubmed: 20709201
J Biol Chem. 2010 Nov 5;285(45):34408-18
pubmed: 20817733
Cell Mol Life Sci. 2011 Jan;68(2):205-18
pubmed: 20848155
Cell Res. 2011 Jan;21(1):103-15
pubmed: 21187859
Aging (Albany NY). 2011 Oct;3(10):913-9
pubmed: 21990145
Cell Signal. 2012 Apr;24(4):835-45
pubmed: 22182507
Blood. 2012 Mar 8;119(10):2368-75
pubmed: 22262768
J Clin Invest. 2012 Mar;122(3):787-95
pubmed: 22378047
Cell Div. 2012 Mar 06;7(1):7
pubmed: 22394506
Free Radic Biol Med. 2012 Jul 1;53(1):72-80
pubmed: 22583699
Blood. 2013 Jan 24;121(4):666-78
pubmed: 23190530
Proc Natl Acad Sci U S A. 2013 Jan 8;110(2):618-23
pubmed: 23267096
Exp Hematol. 2013 May;41(5):432-43.e7
pubmed: 23376999
Nat Commun. 2013;4:1886
pubmed: 23695680
Nat Rev Mol Cell Biol. 2013 Nov;14(11):727-36
pubmed: 24129419
Mol Cell Biol. 2013 Dec;33(24):4971-84
pubmed: 24144979
EMBO Rep. 2014 Jan;15(1):46-61
pubmed: 24375677
Exp Cell Res. 2014 Aug 1;326(1):57-67
pubmed: 24880124
Biomaterials. 2016 Sep;101:47-59
pubmed: 27267627
Cell Rep. 2016 Sep 6;16(10):2736-2748
pubmed: 27568561
Cell. 1986 Aug 29;46(5):705-16
pubmed: 3091258
J Cell Physiol. 1983 Nov;117(2):189-94
pubmed: 6605349
Nature. 1995 Jul 13;376(6536):167-70
pubmed: 7603567
Science. 1995 Sep 8;269(5229):1427-9
pubmed: 7660125
Am J Pathol. 1995 Apr;146(4):868-75
pubmed: 7717454
J Biol Chem. 1994 Dec 2;269(48):30429-35
pubmed: 7982957
Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):7071-5
pubmed: 8041748
Proc Natl Acad Sci U S A. 1994 Feb 1;91(3):1168-72
pubmed: 8302848
Science. 1996 Nov 1;274(5288):782-4
pubmed: 8864118
J Exp Med. 1997 May 5;185(9):1661-70
pubmed: 9151903
Blood Cells Mol Dis. 1997 Dec;23(3):422-33
pubmed: 9454686
Science. 1998 Dec 11;282(5396):2085-8
pubmed: 9851930

Auteurs

Eugénie Koumakis (E)

INSERM UMR_S1151 CNRS UMR8253 Institut Necker-Enfants Malades (INEM) Université Paris Descartes, Paris, France. eugenie.koumakis@aphp.fr.
Rheumatology Department, Cochin Hospital, APHP, Paris, France. eugenie.koumakis@aphp.fr.
Centre de Référence des Maladies Rares du Métabolisme du Calcium et du Phosphate, site constitutif, Cochin Hospital, Paris, France. eugenie.koumakis@aphp.fr.

Joëlle Millet-Botti (J)

INSERM UMR_S1151 CNRS UMR8253 Institut Necker-Enfants Malades (INEM) Université Paris Descartes, Paris, France.
Université Paris Diderot-Sorbonne Paris Cité, F-75993, Paris, France.

Jamel El Benna (JE)

INSERM U1149, CNRS-ERL8252, Centre de Recherche sur l'Inflammation, Université Paris Diderot, Sorbonne Paris Cité, Laboratoire d'Excellence Inflamex, Faculté de Médecine, Site Xavier Bichat, 75018, Paris, France.

Christine Leroy (C)

INSERM UMR_S1151 CNRS UMR8253 Institut Necker-Enfants Malades (INEM) Université Paris Descartes, Paris, France.

Valérie Boitez (V)

INSERM UMR_S1151 CNRS UMR8253 Institut Necker-Enfants Malades (INEM) Université Paris Descartes, Paris, France.

Patrice Codogno (P)

INSERM UMR_S1151 CNRS UMR8253 Institut Necker-Enfants Malades (INEM) Université Paris Descartes, Paris, France.

Gérard Friedlander (G)

INSERM UMR_S1151 CNRS UMR8253 Institut Necker-Enfants Malades (INEM) Université Paris Descartes, Paris, France.

Anne Forand (A)

Inovarion, Paris, France.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH